HARVARD BIOSCIENCE, INC. Long-Lived Assets
HARVARD BIOSCIENCE, INC. (HBIO) had Long-Lived Assets of $19.38 million as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-03-13
- 2025-12-31: Long-Lived Assets $19.38M.
- 2024-12-31: Long-Lived Assets $22.18M.
- 2023-12-31: Long-Lived Assets $24.58M.
- 2022-12-31: Long-Lived Assets $29.97M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2025-12-31 | $19.38M 10-K · filed 2026-03-13 | |
| 2024-12-31 | $22.18M 10-K · filed 2026-03-13 | |
| 2023-12-31 | $24.58M 10-K · filed 2025-03-14 | |
| 2022-12-31 | $29.97M 10-K · filed 2024-03-07 | |
| 2021-12-31 | $37.46M 10-K · filed 2023-03-09 | |
| 2020-12-31 | $44.62M 10-K · filed 2022-03-11 | |
| 2019-12-31 | $50.51M 10-K/A · filed 2021-03-17 | $42.05M 10-K · filed 2020-03-16 |
| 2018-12-31 | $50.43M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $20.10M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $20.10M 10-K · filed 2019-03-18 | $21.77M 10-K · filed 2017-03-17 |
| 2015-12-31 | $26.77M 10-K · filed 2017-03-17 | |
| 2014-12-31 | $26.34M 10-K · filed 2016-04-29 | |
| 2013-12-31 | $23.38M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |